4.8 Article

Intermolecular enolate heterocoupling: Scope, mechanism, and application

期刊

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
卷 130, 期 34, 页码 11546-11560

出版社

AMER CHEMICAL SOC
DOI: 10.1021/ja804159y

关键词

-

资金

  1. The Scripps Research Institute
  2. Amgen
  3. AstraZeneca
  4. Beckman Foundation
  5. Bristol-Myers Squibb
  6. DuPont
  7. Eli Lilly
  8. GlaxoSmithKline
  9. Pfizer
  10. Roche
  11. Searle Scholarship Fund
  12. Sloan Foundation
  13. NIH (NIGMS)

向作者/读者索取更多资源

This full account presents the background on, discovery of, and extensive insight that has been gained into the oxidative intermolecular coupling of two different carbonyl species. Optimization of this process has culminated in reliable and scalable protocols for the union of amides, imides, ketones, and oxindoles using soluble copper(II) or iron(Ill) salts as oxidants. Extensive mechanistic studies point to a metal-chelated single-electron-transfer process in the case of copper(II), while iron(ill)-based couplings appear to proceed through a non-templated heteroclimerization. This work presents the most in-depth findings on the mechanism of oxidative enolate coupling to date. The scope of oxidative enolate heterocoupling is extensive (40 examples) and has been shown to be efficient even on a large scale (gram-scale or greater). Finally, the method has been applied to the total synthesis of the unsymmetrical lignan lactone (-)-bursehernin and a medicinally important 2,3-disubstituted succinate derivative.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据